Suppr超能文献

秋水仙碱在人体中的毒代动力学:10例患者的组织、血浆和尿液数据分析

Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.

作者信息

Rochdi M, Sabouraud A, Baud F J, Bismuth C, Scherrmann J M

机构信息

Institut National de la Santé et de la Recherche Médicale, Unité 26, Hôpital Fernand Widal, Paris, France.

出版信息

Hum Exp Toxicol. 1992 Nov;11(6):510-6. doi: 10.1177/096032719201100612.

Abstract
  1. A specific and sensitive radioimmunoassay was used to study the toxicokinetics of colchicine in seven cases of acute human poisoning. Post-mortem tissue concentrations of colchicine were measured in three further cases. Depending on the time of patient admission, two disposition processes could be observed. The first, in three patients, admitted early, showed a bi-exponential plasma colchicine decrease, with distribution half-lives of 30, 45 and 90 min. The second, in four patients, admitted late, showed a mono-exponential decrease. Plasma terminal half-lives ranged from 10.6 to 31.7 h for both groups. 2. Pharmacokinetic analysis of urine colchicine data was performed for two patients. The fraction of unchanged colchicine excreted in urine was about 30%, renal clearance was about 13 l h-1 and three-fold less than total body clearance (39 l h-1). The apparent volume of distribution was 21 l kg-1. 3. Post-mortem tissue analysis showed an ubiquitous colchicine distribution. Colchicine accumulated at high concentrations in the bone marrow (more than 600 ng g-1), testicle (400 ng g-1), spleen (250 ng g-1), kidney (200 ng g-1), lung (200 ng g-1) and heart (95 ng g-1); it was also found in the brain (125 ng g-1). 4. This toxicokinetic study shows that after massive ingestion, the disposition parameters and kinetics of colchicine are not markedly modified from those occurring in healthy volunteers. The absorption process was not delayed and the distribution and elimination half-lives were in the range known to occur with therapeutic doses.
摘要
  1. 采用一种特异性和敏感性均高的放射免疫分析法,对7例急性人体中毒病例进行秋水仙碱的毒代动力学研究。另外对3例病例测定了死后组织中秋水仙碱的浓度。根据患者入院时间,可观察到两种处置过程。第一种情况,3例早期入院患者,其血浆中秋水仙碱呈双指数下降,分布半衰期分别为30、45和90分钟。第二种情况,4例晚期入院患者,其血浆中秋水仙碱呈单指数下降。两组患者的血浆终末半衰期在10.6至31.7小时之间。2. 对2例患者的尿中秋水仙碱数据进行了药代动力学分析。尿中排泄的未变化秋水仙碱比例约为30%,肾清除率约为13 l/h,比总体清除率(39 l/h)低三倍。表观分布容积为21 l/kg。3. 死后组织分析显示秋水仙碱分布广泛。秋水仙碱在骨髓(超过600 ng/g)、睾丸(400 ng/g)、脾脏(250 ng/g)、肾脏(200 ng/g)、肺(200 ng/g)和心脏(95 ng/g)中高浓度蓄积;在大脑中也有发现(125 ng/g)。4. 这项毒代动力学研究表明,大量摄入后,秋水仙碱的处置参数和动力学与健康志愿者相比无明显改变。吸收过程未延迟,分布和消除半衰期在治疗剂量时已知的范围内。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验